Garrett Nichols is Chief Medical Officer of Candel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Candel Therapeutics, Inc.
30 Nov 23
4
Candel Therapeutics, Inc.
28 Nov 23
4
Candel Therapeutics, Inc.
2 May 23
4
Candel Therapeutics, Inc.
30 Nov 22
4
Candel Therapeutics, Inc.
14 Sep 22
3
Candel Therapeutics, Inc.
14 Sep 22
4
CHIMERIX INC
11 Feb 20
4
CHIMERIX INC
23 Jan 20
4
CHIMERIX INC
8 Jan 20
4
CHIMERIX INC
26 Jul 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Nov 23 | CADL Candel Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9 | 12,175 | 10.96 k | 135,126 |
26 Nov 23 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 88,822 | 0.00 | 147,301 |
28 Apr 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.29 | 45,000 | 58.05 k | 45,000 |
28 Nov 22 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 58,479 | 0.00 | 58,479 |